Cribstone Capital Management’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$4.49M Sell
184,733
-39,567
-18% -$958K 2.62% 8
2022
Q3
$5.41M Buy
224,300
+9,612
+4% +$237K 3.35% 4
2022
Q2
$5.3M Buy
214,688
+6,042
+3% +$150K 3.26% 6
2022
Q1
$5.27M Buy
208,646
+28,167
+16% +$727K 2.88% 10
2021
Q4
$4.77M Buy
180,479
+58,328
+48% +$1.55M 2.65% 12
2021
Q3
$3.28M Buy
122,151
+35,726
+41% +$964K 1.95% 15
2021
Q2
$2.33M Buy
86,425
+21,295
+33% +$575K 1.42% 20
2021
Q1
$1.75M Buy
65,130
+27,785
+74% +$752K 1.15% 26
2020
Q4
$1.02M Buy
+37,345
New +$1.02M 0.7% 36

Other funds holding IBDQ

Cribstone Capital Management's IBDQ Position: Q4 2022 in Review

Cribstone Capital Management reduced its iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) stake by 18% in Q4 2022, selling an estimated $958K and leaving 184,733 shares worth $4.49M. The position accounts for 2.62% of the portfolio, ranked #8.

Cribstone Capital Management first reported a position in IBDQ in Q4 2020 and has held it in 9 quarters since. The position peaked at $5.41M in Q3 2022. 233 funds tracked by Wall St. Rank hold IBDQ as of Q4 2022.

  • Cribstone Capital Management held 184,733 shares of iShares iBonds Dec 2025 Term Corporate ETF worth $4.49M as of Q4 2022.
  • Cribstone Capital Management sold 39,567 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2022, an estimated $958K.
  • iShares iBonds Dec 2025 Term Corporate ETF made up 2.62% of Cribstone Capital Management's portfolio in Q4 2022, its #8 holding.
  • Cribstone Capital Management first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2020 and has held it in 9 quarters since.
  • Cribstone Capital Management's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $5.41M in Q3 2022.
  • 233 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.